Integral Health Asset Management »

Travere Therapeutics shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.7M 100k 17.42
2021-03-31 $375k 15k 25.00

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics